We expect a normalization relative to the weak Q2. Although, we still forecast a lower margin and slightly reduced EBITA YoY. However, with a share price of SEK ~150 and valuation of 7x EBITA 2020E, we believe the market would consider a Q3 somewhat in line with our forecast as a relief. Proact will publish its Q3’19 on Thursday, October 17.